|

Letermovir 480 MG [Prevymis] Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • University of Pennsylvania1

Indications

  • Transplant-Related Disorder1
  • Heart Disease1
  • Cytomegalovirus Infections1

Philadelphia, Pennsylvania1 trial

Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients

Penn Medicine at the University of Pennsylvania

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.